14 Oct 2025

"Schoenherr Advises Polska Grupa Militarna on PLN 250 Million Financing from Fidera Group for Advanced Ammunition Development"

"Schoenherr has advised Polska Grupa Militarna on a PLN 250 million financing deal with Fidera Group. The financing includes a PLN 100 million investment in new shares, a PLN 30 million loan to Zaklady Sprzetu Precyzyjnego Niewiadow, and a PLN 120 million equity investment in EG Polska. The funds will be used to enhance ammunition production capabilities, including the construction of a new factory with an initial capacity of 120,000 155mm artillery shells per year. Polska Grupa Militarna specializes in military technologies and defense products."

Schoenherr has advised Polska Grupa Militarna and its group companies in a significant financing transaction involving Fidera Group. The transaction encompasses a PLN 250 million financing package, which includes Fidera's subscription to newly issued series K shares in Polska Grupa Militarna for PLN 100 million, a PLN 30 million loan to Zaklady Sprzetu Precyzyjnego Niewiadow, and a direct equity investment of PLN 120 million in EG Polska. The funds are intended to enhance the development of advanced ammunition elaboration capacity, specifically for the construction of a new factory with an initial production capacity of 120,000 units of 155 millimeter artillery shells per year, scalable up to 180,000 units annually. The Schoenherr team involved in this transaction included Partner Szymon Okon, Counsel Dawid Brudzisz, and Attorney-at-Law Urszula Zleszycka.
Read the full story

Register for free to access daily news.

Register Free
We use cookies to improve your experience, analyze traffic, and serve targeted ads. Read our Cookie Policy.

Cookie Preferences

Customize your cookie settings. Necessary cookies are always enabled.

Strictly Necessary

Required for the website to function (e.g. login, security).

Analytics & Statistics

Help us understand how visitors interact with the website.

Marketing & Ads

Used to deliver relevant ads and track effectiveness.